Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: Correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism

Medical Mycology

Volumn 51, Issue 1, 2013, Pages 72-82

  Petraitis, Vidmantas ^a,b   Petraitiene, Ruta ^a,b   Antachopoulos, Charalampos ^a,h   Hughes, Johanna E ^a   Cotton, Margaret P ^a   Kasai, Miki ^a   Harrington, Susan ^c,d   Gamaletsou, Maria N ^b,e   Bacher, John D ^f   Kontoyiannis, Dimitrios P ^g   Roilides, Emmanuel ^a,h   Walsh, Thomas J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cunninghamella bertholletiae; Pulmonary mucormycosis; Rabbits; Virulence

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CUNNINGHAMELLA BERTHOLLETIAE; FEMALE; FUNGAL SPORE GERMINATION; FUNGAL VIRULENCE; IN VITRO STUDY; LUNG EDEMA; LUNG INFARCTION; LUNG INFECTION; LUNG MUCORMYCOSIS; LUNG WEIGHT; MUCOR CIRCINELLOIDES; MUCORMYCOSIS; NEUTROPENIA; NONHUMAN; POLYMERASE CHAIN REACTION; RABBIT; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; SPORANGIOSPORE; SURVIVAL;

EID: 84870948466     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.690107     Document Type: Article

References (39)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
2. Simitsopoulou M, Georgiadou E, Walsh TJ, Roilides E. C unninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Med Mycol 2009; 48: 720-724.
3. Antachopoulos C, Meletiadis J, Roilides E, et al. Relationship between metabolism and biomass of medically important zygomycetes. Med Mycol 2006; 44: 429-438.
4. Kurtzman CP, Robnett CJ. Identifi cation of clinically important ascomycetous yeasts based on nucleotide divergence in the 5 end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-1223.
5. Peterson SW, Kurtzman CP. Phylogenetic relationships among species of the genus Issatchenkia Kudriavzev. Antonie Van Leeuwenhoek 1990; 58: 235-240.
6. White TJ, Bruns T, Lee SB, Taylor JW. Amplifi cation and sequencing of fungal ribosomal RNA genes for phylogenetics. PCRYProtocols and ApplicationsYA Laboratory Manual. New York: Academic Press, 1990: 315-322.
7. National Research Council Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources CoLS. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 1996.
8. Walsh TJ, Bacher J, Pizzo PA. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Lab Anim Sci 1988; 38: 467-471.
9. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: Pynergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003; 187: 1834-1843.
10. Kasai M, Harrington SM, Francesconi A, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol 2008; 46: 3690-3702.
11. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, Inc; 1982: 455-459.
12. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non- Rhizopus, -Mucor, and - Lichtheimia species. Clin Microbiol Rev 2011; 24: 411-445.
13. Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited infl ammatory response. J Infect 2009; 59: 134-138.
14. Brennan RO, Crain BJ, Proctor AM, Durack DT. Cunninghamella: A newly recognized cause of rhinocerebral mucormycosis. Am J Clin Pathol 1983; 80: 98-102.
15. Cohen-Abbo A, Bozeman PM, Patrick CC. C unninghamella infections: Review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis 1993; 17: 173-177.
16. Kiehn TE, Edwards F, Armstrong D, Rosen PP, Weitzman I. Pneumonia caused by Cunninghamella bertholletiae complicating chronic lymphatic leukemia. J Clin Microbiol 1979; 10: 374-379.
17. Kontoyianis DP, Vartivarian S, Anaissie EJ, et al. Infections due to Cunninghamella bertholletiae in patients with cancer: Report of three cases and review. Clin Infect Dis 1994; 18: 925-928.
18. Kwon-Chung KJ, Young RC, Orlando M. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol 1975; 64: 544-548.
19. Maloisel F, Dufour P, Waller J, et al. Cunninghamella bertholletiae: An uncommon agent of opportunistic fungal infection. Case report and review. Nouv Rev Fr Hematol 1991; 33: 311-315.
20. Ng TT, Campbell CK, Rothera M, et al. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis 1994; 19: 313-316.
21. Quinio D, Karam A, Leroy JP, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol 2004; 42: 177-180.
22. Rex JH, Ginsberg AM, Fries LF, Pass HI, Kwon-Chung KJ. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev Infect Dis 1988; 10: 1187-1194.
23. Righi E, Giacomazzi CG, Lindstrom V, et al. A case of C unninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia 2008; 165: 407-410.
24. Zeilender S, Drenning D, Glauser FL, Bechard D. Fatal C unninghamella bertholletiae infection in an immunocompetent patient. Chest 1990; 97: 1482-1483.
25. Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis 2002; 40: 842-846.
26. Antachopoulos C, Demchok JP, Roilides E, Walsh TJ. Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of fi lamentous fungi. Mycoses 2010; 53: 321-328.
27. Meshulam T, Levitz SM, Christin L, Diamond RD. A simplifi ed new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis 1995; 172: 1153-1156.
28. Ma LJ, Ibrahim AS, Skory C, et a l. Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication. PLoS Genet 2009; 5: E1000549.
29. Liu M, Spellberg B, Phan QT, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest 2010; 120: 1914-1924.
30. Pongas GN, Ben-Ami R, Lewis RE, Walsh TJ, Kontoyiannis DP. Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fl y model of mucormycosis. Antimicrob Agents Chemother 2009; 53: 4569.
31. Lewis RE, Pongas GN, Albert N, et a l. Activity of deferasirox in Mucorales: Infl uences of species and exogenous iron. Antimicrob Agents Chemother 2011; 55: 411-413.
32. Chamilos G, Lewis RE, Hu J, et a l. D rosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci USA 2008; 105: 9367-9372.
33. Vallor AC, Kirkpatrick WR, Najvar LK, et al. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008; 52: 2593-2598.
34. Noble WC, Clayton YM. Fungi in the air of hospital wards. J Gen Microbiol 1963; 32: 397-402.
35. Walsh TJ, Dixon DM. Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur J Epidemiol 1989; 5: 131-142.
36. Walsh TJ, Pizzo PA. Nosocomial fungal infections: A classifi cation for hospital-acquired fungal infections and mycoses arising from endogenous fl ora or reactivation. Annu Rev Microbiol 1988; 42: 517-545.
37. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: Epidemiology, diagnosis, and treatment. Med Mycol 2007; 45: 321-346.
38. Walsh TJ, McEntee C, Dixon DM. Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans. J Clin Microbiol 1987; 25: 931-932.
39. Gerson SL, Talbot GH, Hurwitz S, et a l. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-351.